News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
858,817 Results
Type
Article (87295)
Company Profile (739)
Press Release (770756)
Multimedia
Podcasts (166)
Webinars (27)
Section
Business (232998)
Career Advice (4137)
Deals (39782)
Drug Delivery (133)
Drug Development (91221)
Employer Resources (202)
FDA (18256)
Job Trends (17392)
News (397257)
Policy (39907)
Tag
Academia (3003)
Academic (2)
Accelerated approval (17)
Adcomms (35)
Allergies (121)
Alliances (56979)
ALS (138)
Alzheimer's disease (1653)
Antibody-drug conjugate (ADC) (209)
Approvals (18259)
Artificial intelligence (465)
Autoimmune disease (51)
Automation (24)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (154)
Biotechnology (484)
Bladder cancer (120)
Brain cancer (47)
Breast cancer (450)
Cancer (3618)
Cardiovascular disease (318)
Career advice (3551)
Career pathing (36)
CAR-T (235)
CDC (52)
Cell therapy (642)
Cervical cancer (31)
Clinical research (75051)
Collaboration (1313)
Company closure (4)
Compensation (874)
Complete response letters (56)
COVID-19 (2946)
CRISPR (80)
C-suite (521)
Cystic fibrosis (130)
Data (3929)
Decentralized trials (2)
Denatured (59)
Depression (105)
Diabetes (437)
Diagnostics (7062)
Digital health (31)
Diversity (11)
Diversity, equity & inclusion (49)
Drug discovery (223)
Drug pricing (170)
Drug shortages (36)
Duchenne muscular dystrophy (186)
Earnings (98656)
Editorial (53)
Employer branding (25)
Employer resources (171)
Events (132517)
Executive appointments (961)
FDA (20549)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (4)
Frontotemporal dementia (11)
Funding (1164)
Gene editing (167)
Generative AI (45)
Gene therapy (509)
GLP-1 (1004)
Government (5358)
Grass and pollen (7)
Guidances (334)
Healthcare (20937)
HIV (48)
Huntington's disease (35)
IgA nephropathy (52)
Immunology and inflammation (229)
Immuno-oncology (19)
Indications (50)
Infectious disease (3169)
Inflammatory bowel disease (180)
Inflation Reduction Act (13)
Influenza (88)
Intellectual property (172)
Interviews (815)
IPO (17923)
IRA (59)
Job creations (5196)
Job search strategy (2863)
Kidney cancer (15)
Labor market (73)
Layoffs (629)
Leadership (31)
Legal (10145)
Liver cancer (91)
Longevity (12)
Lung cancer (518)
Lymphoma (252)
Machine learning (24)
Management (66)
Manufacturing (591)
MASH (124)
Medical device (14839)
Medtech (14857)
Mergers & acquisitions (22687)
Metabolic disorders (1108)
Multiple sclerosis (130)
NASH (23)
Neurodegenerative disease (194)
Neuropsychiatric disorders (53)
Neuroscience (2598)
NextGen: Class of 2025 (7687)
Non-profit (5095)
Now hiring (55)
Obesity (549)
Opinion (304)
Ovarian cancer (122)
Pain (157)
Pancreatic cancer (154)
Parkinson's disease (220)
Partnered (28)
Patents (391)
Patient recruitment (278)
Peanut (57)
People (66102)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (23134)
Phase II (32598)
Phase III (24525)
Pipeline (2535)
Policy (284)
Postmarket research (3554)
Preclinical (10447)
Press Release (72)
Prostate cancer (180)
Psychedelics (51)
Radiopharmaceuticals (281)
Rare diseases (621)
Real estate (7415)
Recruiting (78)
Regulatory (27782)
Reports (64)
Research institute (2680)
Resumes & cover letters (650)
Rett syndrome (12)
RNA editing (15)
RSV (66)
Schizophrenia (123)
Series A (193)
Series B (145)
Service/supplier (30)
Sickle cell disease (78)
Special edition (25)
Spinal muscular atrophy (170)
Sponsored (40)
Startups (4315)
State (2)
Stomach cancer (17)
Supply chain (96)
Tariffs (84)
The Weekly (105)
Vaccines (1020)
Venture capital (64)
Weight loss (383)
Women's health (57)
Worklife (21)
Date
Today (118)
Last 7 days (510)
Last 30 days (2527)
Last 365 days (33824)
2025 (24356)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1278)
Alabama (78)
Alaska (7)
Arizona (299)
Arkansas (14)
Asia (50843)
Australia (8931)
California (9033)
Canada (2751)
China (858)
Colorado (382)
Connecticut (403)
Delaware (248)
Europe (116788)
Florida (1329)
Georgia (305)
Hawaii (3)
Idaho (67)
Illinois (790)
India (47)
Indiana (441)
Iowa (19)
Japan (280)
Kansas (123)
Kentucky (35)
Louisiana (20)
Maine (75)
Maryland (1229)
Massachusetts (6793)
Michigan (301)
Minnesota (549)
Mississippi (4)
Missouri (113)
Montana (33)
Nebraska (26)
Nevada (104)
New Hampshire (76)
New Jersey (2498)
New Mexico (32)
New York (2465)
North Carolina (1374)
North Dakota (10)
Northern California (4029)
Ohio (283)
Oklahoma (19)
Oregon (50)
Pennsylvania (1883)
Puerto Rico (19)
Rhode Island (45)
South America (1655)
South Carolina (45)
South Dakota (1)
Southern California (3442)
Tennessee (144)
Texas (1409)
United States (33494)
Utah (269)
Virginia (239)
Washington D.C. (82)
Washington State (778)
West Virginia (4)
Wisconsin (94)
Wyoming (1)
There are 858,817 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Job Trends
6 Companies Hiring Now in Pennsylvania
Looking for a biopharma job in Pennsylvania? Check out the
BioSpace
list of six companies hiring life sciences professionals like you.
September 25, 2025
·
1 min read
·
Angela Gabriel
Job Trends
$100,000 H-1B Fee Leaves Biopharma Grappling With Impact
The Trump administration’s recently announced fee for new H-1B visa petitions is “completely unreasonable,” an immigration attorney told
BioSpace
. Attorneys and talent acquisition experts discuss how the fee could impact biopharma and confusion around the proclamation.
September 25, 2025
·
6 min read
·
Angela Gabriel
Press Releases
Envoy Medical Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
September 25, 2025
·
5 min read
Press Releases
MMS Named Finalist in Citeline’s 2025 Scrip Awards for Best Contract Research Organization (CRO) – Specialist Providers
September 25, 2025
·
1 min read
Pancreatic cancer
Immuneering Asset Nearly Doubles Overall Survival in Pancreatic Cancer After 9 Months
Truist analysts called the results “encouraging” while pointing out certain unknowns in the data. Immuneering plans to kick off a registrational trial for atebimetinib later this year.
September 25, 2025
·
2 min read
·
Tristan Manalac
Weight loss
Lilly Cuts Mid-Stage Obesity Study of Muscle-Sparing Antibody
The decision to stop the Phase IIb study was driven by “strategic business reasons,” according to a federal clinical trials database.
September 25, 2025
·
2 min read
·
Tristan Manalac
FDA
FDA Details Thinking for Streamlining Development of Cell, Gene, Regenerative Therapies
Three draft recommendation documents published on Wednesday are intended to guide drug sponsors and accelerate the development of cell and gene therapies.
September 25, 2025
·
2 min read
·
Tristan Manalac
Layoff Tracker
Rising Pharma Lowers Headcount After Closing Factories
Follow along as
BioSpace
tracks job cuts and restructuring initiatives throughout 2025.
September 25, 2025
·
206 min read
·
BioSpace Editorial Staff
Rare diseases
Harmony Fails Pivotal Fragile X Syndrome Trial, Blames High Placebo Response
While Harmony management has not disclosed future plans for ZYN002, Jefferies analysts expect the asset to be shelved.
September 25, 2025
·
1 min read
·
Tristan Manalac
Press Releases
Covalon Presents Evidence-Backed Innovations Making a Difference for Critically Ill Children at APHON
September 25, 2025
·
6 min read
1 of 85,882
Next
